Immune-Onc Therapeutics

Immune-Onc Therapeutics: Funding & valuation

Immune-Onc Therapeutics has $7M paid in by investors, lenders and donors.

Financials

Funding rounds, investors and revenue on record.

$7MTotal raised
$2.1MPublic grants1 public grant
GrantLatest round
2Rounds and grants
Money by yearUSD, rounds and grants
2020$2.1M1 record
2016$7M1 record
Largest rounds and grants
Sources: funding announcements, grant and company registers

Money

Immune-Onc Therapeutics has $7M paid in by investors, lenders and donors.

$7MPaid in
StagePaidSignedAnnouncedSourceFiledAnnouncedPress
Money in
Grant
Aug 2020 · Grant
$2.1MPaid
Equity raised
Jul 2016 · Venture round
$7MPaid
Research grantsNIH, NSF and UKRI awards
$1.1Mfiscal 2021
1awards on record
Non-clinical Combination Pharmacology Studies and Phase 1 Clinical Development of IO-202 in Acute Myeloid Leukemia (AML)
NIH · NCI · R44 · Jul 2021
$1.1M
Every row links its own source. A flow two sources state counts once; a figure a source does not state reads "not stated".